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Abstract
Background: Retinal ganglion cells expressing the photopigment melanopsin are intrinsically photosensitive (ipRGCs).
These ganglion cell photoreceptors send axons to several central targets involved in a variety of functions. Within the retina
ipRGCs provide excitatory drive to dopaminergic amacrine cells via glutamatergic signals and ipRGCs are coupled to wide-
field GABAergic amacrine cells via gap junctions. However, the extent to which ipRGCs are coupled to other retinal neurons
in the ganglion cell layer via gap junctions is unclear. Carbenoxolone, a widely employed gap junction inhibitor, greatly
reduces the number of retinal neurons exhibiting non-rod, non-cone mediated light-evoked Ca
2+ signals suggesting
extensive intercellular coupling between ipRGCs and non-ipRGCs in the ganglion cell layer. However, carbenoxolone may
directly inhibit light-evoked Ca
2+ signals in ipRGCs independent of gap junction blockade.
Methodology/Principal Findings: To test the possibility that carbenoxolone directly inhibits light-evoked Ca
2+ responses in
ipRGCs, the light-evoked rise in intracellular Ca
2+ ([Ca
2+]i) was examined using fura-2 imaging in isolated rat ipRGCs
maintained in short-term culture in the absence and presence of carbenoxolone. Carbenoxolone at 50 and 100 mM
concentrations completely abolished the light-evoked rise in [Ca
2+]i in isolated ipRGCs. Recovery from carbenoxolone
inhibition was variable.
Conclusions/Significance: We demonstrate that the light-evoked rise in [Ca
2+]i in isolated mammalian ganglion cell
photoreceptors is inhibited by carbenoxolone. Since the light-evoked increase in [Ca
2+]i in isolated ipRGCs is almost entirely
due to Ca
2+ entry via L-type voltage-gated calcium channels and carbenoxolone does not inhibit light-evoked action
potential firing in ipRGCs in situ, carbenoxolone may block the light-evoked increase in [Ca
2+]i in ipRGCs by blocking L-type
voltage-gated Ca
2+ channels. The ability of carbenoxolone to block evoked Ca
2+ responses must be taken into account
when interpreting the effects of this pharmacological agent on retinal or other neuronal circuits, particularly if a change in
[Ca
2+]i is the output being measured.
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Introduction
Retinal ganglion cells expressing melanopsin are intrinsically
photosensitive (ipRGCs) [1,2] and send signals to a variety of cen-
tral targets involved in visual perception and non-image forming
functions [2–8]. Within the retina, ipRGCs provide light-evoked
excitatory (glutamatergic) drive to a subset of dopaminergic
amacrine cells that play a key role in reconfiguring retinal function
according to prevailing illumination conditions [9]. Signals from
ipRGCs may also propagate to other neurons in the ganglion cell
layer of the retina, such as wide-field GABAergic amacrine cells,
via electrical coupling through gap junctions [10].
Gap junctions/electrical synapses are abundant throughout the
plexiform layers of the retina and are diverse in their ultrastruc-
tural morphology [11,12]. Electrical coupling via gap junctions
plays an important role in communication among many types of
retinal neuron [11,13]. Extensive gap junction-mediated coupling
between ipRGCs and other retinal neurons in the ganglion cell
layer was first reported by Sekaran and colleagues [14,15] based
on the large reduction (.50%) of retinal cells exhibiting light-
evoked increases in cytosolic Ca
2+ in the presence of carbenox-
olone, a compound widely used to block gap junctions [16].
However, carbenoxolone similarly applied to the retina main-
tained in vitro for multielectrode recording does not decrease the
number of retinal neurons generating light-evoked action poten-
tials [17,18]. The explanation for these divergent results is cur-
rently unknown but may be related to the different endpoints that
were measured in these studies: light-evoked action potentials
[17,18] vs light-evoked calcium responses [14,15].
The primary cellular mechanism mediating the light-evoked
elevation in ipRGC intracellular calcium levels ([Ca
2+]i)i sb yC a
2+
influx through L-type voltage-gated calcium channels (VGCC)
(Cav1 of more recent nomenclature [19]); <90% of the light-
evoked increase in ipRGC [Ca
2+]i in isolated cells in vitro was
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depolarization and action potential firing [20]. Thus, if in addition
to blocking gap junctions, carbenoxolone also acts downstream of
light-evoked depolarization and action potential generation to
inhibit L-type VGCC, then carbenoxolone would inhibit the light-
evoked elevation in [Ca
2+]i while having no measurable effect on
light-evoked action potential firing in ipRGCs. Indeed, carbenox-
olone does suppress Ca
2+ signals in isolated amphibian cone
photoreceptors and reduces depolarization-evoked [Ca
2+]i re-
sponses in amphibian retinal slices by blocking voltage-gated
calcium channels [21]. It is not known if carbenoxolone acts
directly on mammalian ganglion cell photoreceptors to inhibit
light-evoked Ca
2+ responses.
In this study we examined light-evoked calcium responses of
isolated ipRGCs maintained in vitro in the absence and presence
of carbenoxolone. Carbenoxolone blocked completely the light-
evoked increase in [Ca
2+]i in isolated ipRGCs. The data indicate
that evaluation of gap junction coupling using carbenoxolone as
a blocker and changes in [Ca
2+]i as an output measure must
consider a possible direct effect of this compound on membrane
calcium channels.
Results
Light-evoked Ca
2+ response in isolated ipRGCs
Calcium imaging experiments were conducted on cultured
melanopsin-expressing ipRGCs 1–2 days after their isolation from
neonatal rats. Retinal ganglion cells isolated by melanopsin-
immunopanning were cultured at low density allowing analyses to
be performed on individual cells that were not in physical contact
with other ipRGCs. Melanopsin-immunopanned RGCs retained
their intrinsic photosensitivity in vitro and responded to light stimuli
with an elevation in [Ca
2+]i that rapidly returned toward baseline
levels after termination of the light stimulus (Fig. 1).
The effect of carbenoxolone on the light-evoked Ca
2+
response in ipRGCs
To determine the direct effect of the gap junction blocker
carbenoxolone on light-induced Ca
2+ responses in individual
ipRGCs, carbenoxolone was delivered to the recording chamber
after two light-evoked Ca
2+ responses had been recorded.
Carbenoxolone reduced the light-evoked Ca
2+ response in isolated
ipRGCs in a concentration-related manner (0.1–100 mM) al-
though the extent of inhibition was quite variable among ipRGCs
at the intermediate concentrations tested (1 and 10 mM) and
complete inhibition of the light-evoked Ca
2+ response was ob-
served in at least some cells at all concentrations examined except
100 nM. In the presence of 100 mM carbenoxolone, the con-
centration typically used to block gap junctions between neurons
maintained in vitro [14,21–25], the light-induced Ca
2+ response in
individual ipRGCs was completely abolished (1.661.2% of the
baseline light-evoked Ca
2+ response; n=5, p,0.01) (Figs. 2a
and 2b).
Recovery from carbenoxolone inhibition of the light-evoked
Ca
2+ response in individual ipRGCs was evaluated by recording
three light-evoked Ca
2+ responses spaced 15 min apart during
carbenoxolone washout. The level of recovery of the light-evoked
Ca
2+ response was related to the concentration of carbenoxolone
tested with greater recovery at the lower concentrations. However,
recovery of the light-evoked Ca
2+ response was variable; 5 of 20
cells showed complete recovery whereas 8 of the 20 ipRGCs
showed no recovery after 45 min (light-evoked Ca
2+ response
,5% of the base line light-evoked Ca
2+ response, Table 1). These
data are in agreement with findings reported by others indicating
that it is difficult or impossible to reverse the effects of car-
benoxolone [26].
Glutamate-evoked Ca
2+ responses in isolated ipRGCs
In an attempt to demonstrate that ipRGCs remained capable of
generating an evoked Ca
2+ response after 100 mM carbenoxolone
application and washout despite the lack of a light-evoked Ca
2+
response, we examined glutamate-evoked Ca
2+ responses; it has
been shown previously that glutamate application (10–100 mM)
evokes a rise in [Ca
2+]i in isolated ipRGCs [20]. The glutamate-
evoked rise in [Ca
2+]i in ipRGCs could result from Ca
2+ admitted
via NMDA and/or AMPA/kainate-type glutamate receptors and
via the activation of VGCC occurring after membrane depolar-
ization and action potential firing resulting from glutamate
receptor stimulation, as described for immunopanned convention-
al RGCs [27]. We first confirmed that brief glutamate application
(100 mM; 15 sec) evoked action potentials in isolated ipRGCs by
stimulating cells with glutamate in the absence and presence of
Figure 1. Pseudocolored images of fura-2 fluorescence ratios (340/380 nm) for melanopsin-panned retinal ganglion cells before
and during light stimulation. Cells labeled B and C responded to the broad-spectrum 60 sec light pulse with an increased [Ca
2+]i establishing
these cells as ipRGCs. The cell labeled A was unresponsive to the light pulse and the baseline [Ca
2+]i did not change.
doi:10.1371/journal.pone.0022721.g001
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2+ responses in ipRGCs in the absence and presence of carbenoxolone. (a) The light-evoked elevation in [Ca
2+]i
in an isolated ipRGC was completely blocked in the presence of 100 mM carbenoxolone (CBX) with only partial recovery after the third light pulse
presented after 45 min of wash out. (b) Dose-response data illustrating inhibition of baseline light-evoked Ca
2+ response in the presence of 0.1, 1, 10,
50 and 100 mM carbenoxolone. Only ipRGCs showing at least partial recovery after carbenoxolone washout are included. The light-evoked Ca
2+
responses from seven ipRGCs in the absence of carbenoxolone (0 mM) are included. These cells gave four consecutive light-evoked Ca
2+ responses
(values provided are the third light-evoked Ca
2+ response compared to preceding light-evoked Ca
2+ response as baseline). The curve was fit with a
three-parameter logistic equation (EC50=11mM). Non-evoked elevations in [Ca
2+]i in isolated ipRGCs, due to spontaneous action potential firing, are
de-emphasized by plotting data with lightened dashed lines.
doi:10.1371/journal.pone.0022721.g002
Table 1. Carbenoxolone inhibition of the light-evoked Ca
2+ response in solitary ipRGCs in vitro is difficult to reverse.
Carbenoxolone Dose (mM) Recovery of Light-evoked Ca
2+ Response ipRGC (n)
100 complete recovery (30 min) 1
partial recovery 1
no recovery 3
50 complete recovery (15 min) 2
partial recovery 1
no recovery 1
10 no inhibition 2
complete recovery (15 min) 1
partial recovery 3
no recovery 1
1.0 no inhibition 1
complete recovery (15 min) 1
partial recovery 1
no recovery 3
0.1 no inhibition 2
partial recovery 1
Complete Recovery: ipRGCs demonstrating light-evoked Ca
2+ responses during carbenoxolone (CBX) washout (45 min) that were $100% of the light-evoked Ca
2+
response immediately prior to drug treatment were classified as demonstrating complete recovery (n=5). (time elapsed when complete recovery was noted)
Partial Recovery: ipRGCs demonstrating light-evoked Ca
2+ responses during CBX washout (45 min) that were greater than the light-evoked Ca
2+ response during CBX
application and between 50–90% of the light-evoked Ca
2+ response immediately prior to drug treatment were classified as demonstrating partial recovery (n=7).
No Recovery: ipRGCs demonstrating light-evoked Ca
2+ responses during CBX washout (45 min) that remained ,5% of the light-evoked Ca
2+ response immediately prior
to drug treatment were classified as demonstrating no recovery (n=8).
No Inhibition: ipRGCs demonstrating light-evoked Ca
2+ responses in the presence of CBX that were between 95–120% of the preceding light-evoked Ca
2+ response in
the absence of CBX were classified as demonstrating no inhibition (n=5).
doi:10.1371/journal.pone.0022721.t001
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blocking voltage-gated Na
+ channels. TTX (1 mM) significantly
inhibited the glutamate-evoked rise in [Ca
2+]i with responses
43.5610.5% of baseline (n=4, p,0.01) (Fig. 3a,c). In addition,
TTX produced a robust inhibition of the light-evoked increase in
[Ca
2+]i in all cells tested (Fig. 3a), confirming previous observations
[20]. These data suggest that the glutamate-evoked rise in [Ca
2+]i
resulted from Ca
2+ entry via glutamate receptors permeant to
Ca
2+ and with the majority of the elevation in [Ca
2+]i due to
activation of VGCC following action potential generation.
To confirm that VGCC are activated by glutamate in isolated
ipRGCs we stimulated cells with glutamate (100 mM; 15 sec) in
the absence and presence of verapamil, an L-type VGCC
antagonist, that has been shown previously to inhibit light-evoked
activation of L-type VGCC in isolated ipRGCs resulting from
action potential generation [20]. Verapamil (10 mM) significantly
reduced the glutamate-evoked elevation in [Ca
2+]i (29.764.4% of
baseline response, n=8, p,0.01) (Fig. 3b,c). These data and the
TTX data described above suggest that the glutamate-evoked rise
in [Ca
2+]i results from Ca
2+ admitted through glutamate receptors
followed by action potential generation and activation of L-type
VGCC.
Lastly we asked whether the glutamate-evoked rise in [Ca
2+]i is
reduced by carbenoxolone. After establishing that cells were light
responsive and that they responded to glutamate (100 mM; 15 sec)
with an evoked rise in [Ca
2+]i (baseline response), cells were
stimulated with light in the absence of carbenoxolone (for a
baseline Ca
2+ response) followed by light in the presence of
carbenoxolone (100 mM) and then glutamate (100 mM; 15 sec) in
the presence of carbenoxolone. The light-evoked Ca
2+ response
was again completely blocked by 100 mM carbenoxolone, (3.06
0.4% of baseline response, n=7, p,0.001, Student’s t-test)
(Figs. 4a,b) confirming the findings in the initial experiment
described above. Carbenoxolone also significantly reduced the
glutamate-evoked elevation in [Ca
2+]i (54.7612.1% of baseline,
n=7, p,0.01) (Figs. 4a,b).
These latter data indicate that in the presence of 100 mM
carbenoxolone, ipRGCs remained viable and were capable of
generating a glutamate-evoked Ca
2+ response despite their lack of
an increase in [Ca
2+]i in response to light stimulation. This finding
validates the observed inhibition of the light-evoked Ca
2+ response
in the absence of recovery from carbenoxolone in ipRGCs in the
initial experiment above. Comparison of the data from the initial
experiment of 100 mM carbenoxolone inhibition of light-evoked
Ca
2+ responses (n=5) with this last experiment examining
100 mM carbenoxolone inhibition of light-evoked Ca
2+ responses
(n=7) revealed no significant difference in the level of carbenox-
olone inhibition (1.661.2% vs 3.060.4%, p.0.05). It can be con-
cluded that 100 mM carbenoxolone virtually eliminates the light-
evoked elevation in [Ca
2+]i in isolated ipRGCs. In addi-
tion, comparison of the glutamate-evoked Ca
2+ responses in the
presence of TTX, verapamil, or carbenoxolone revealed no
Figure 3. Glutamate-evoked Ca
2+ responses in ipRGCs in the absence and presence of tetrodotoxin or verapamil. (a) The glutamate-
evoked (Glut 100 mM) Ca
2+ response in an isolated ipRGC was reversibly inhibited by tetrodotoxin (TTX, 1 mM) and the light-evoked rise in [Ca
2+]i was
completely blocked. (b) The glutamate-evoked increase in [Ca
2+]i was reversibly inhibited by verapamil (10 mM). (c) Summary (means 6 SEM,
normalized to the pretreatment responses) demonstrating reversible inhibition of the glutamate-evoked rise in [Ca
2+]i by tetrodotoxin (n=4) and
verapamil (n=8). p,0.01, one-way repeated measures ANOVA, Tukey’s post-hoc test compared to initial and recovery responses for TTX and
verapamil.
doi:10.1371/journal.pone.0022721.g003
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pounds on the level of the glutamate-evoked elevation of [Ca
2+]i
(one-way ANOVA, p.0.10).
Discussion
The principal novel finding in this study is the demonstration
that carbenoxolone, a widely used agent for inhibiting neuronal
gap junctions, abolished the light-evoked elevation in [Ca
2+]i in
solitary, isolated mammalian retinal ganglion cell photoreceptors
maintained in short-term culture. Importantly, carbenoxolone
blocked the light-evoked Ca
2+ response by acting directly on the
ipRGCs as these neurons lacked any physical contact with other
ipRGCs or other retinal cells in culture. The effects of car-
benoxolone on evoked-Ca
2+ responses in the present study were
obtained by stimulating isolated, individual mammalian retinal
neuron photoreceptors with light, coupled with non-invasive
calcium imaging. Our findings are in agreement with those of
Vessey and colleagues [21] who examined the effects of car-
benoxolone on calcium currents (with Ba
2+ as a charge carrier)
obtained by depolarizing voltage-clamped amphibian cone photo-
receptors using whole-cell patch-clamp procedures. The data are
consistent with the interpretation that carbenoxolone directly
blocks L-type voltage-gated calcium channels. Although the
possibility that carbenoxolone may have stimulated the release of
unknown tropic factors from cells in the cultures that subsequently
inhibited the evoked Ca
2+ responses can not be entirely eli-
minated, it is clear that the effect of carbenoxolone on the light-
evoked Ca
2+ response in the present study was not the result of
carbenoxolone blocking gap junctions between ganglion cell
photoreceptors.
It was first reported that ipRGCs were extensively coupled to
other cells in the ganglion cell layer of the retina via gap junctions
based on the reduction in the number of cells demonstrating a
light-evoked Ca
2+ response in the presence of carbenoxolone [14,
15]. Sekaran and colleagues measured light-evoked Ca
2+ responses
in ipRGCs using fura-2 AM ratiometric imaging in the absence
and presence of 100 mM carbenoxolone [14], similar to the
procedures used in the current study, but with an important
difference. In the current study light-evoked Ca
2+ responses were
measured in individual ipRGCs in isolation, whereas Sekaran and
co-workers examined light-evoked Ca
2+ responses in retinas
maintained in vitro [14]. It is clear from the present study, that
carbenoxolone applied to retinas in vitro [14,15] would have
inhibited the light-evoked elevation in [Ca
2+]i in ipRGCs, in
addition to blocking gap junction coupling between retinal cells.
This direct action of carbenoxolone on light-evoked Ca
2+
responses in ipRGCs would have resulted in Sekaran and col-
leagues greatly overestimating the extent of coupling between
ipRGCs and other cells in the ganglion cell layer of the retina
[14,15]. It has recently been shown that ipRGCs in the mouse
retina injected with the tracer Neurobiotin are tracer-coupled to
wide-field GABAergic amacrine cells in the ganglion cell layer;
there was no evidence for homologous tracer-coupling of ipRGCs
or heterologous coupling to other types of ganglion cells [10].
Thus, it is possible that following the light-evoked depolarization of
ipRGCs, calcium signals could propagate from ipRGCs to
displaced GABAergic amacrine cells via gap junctions, explaining
the carbenoxolone-induced reduction in measurable light-evoked
Ca
2+ responses in the ganglion cell layer reported by Sekaran and
colleagues [14,15]. However, a more likely explanation for the
large reduction (rather than complete elimination) of the light-
evoked Ca
2+ responses in cells in the ganglion cell layer described
by Sekaran and co-workers [14], is that the carbenoxolone
blockade of light-evoked Ca
2+ responses in ipRGCs in the intact
retina was simply incomplete due to diffusion barriers [14,15].
The interpretation that the inhibitory effect of carbenoxolone
on the light-evoked Ca
2+ response in ipRGCs was due to the
blockade of L-type VGCC is based on several observations. The
primary source for light-evoked elevations in ipRGC [Ca
2+]i is via
L-type VGCC after light-induced depolarization and action po-
tential firing [20]; Vessey and colleagues [21] reported carbenox-
olone inhibition of VGCC in amphibian cone photoreceptors.
However, the light-evoked rise in Ca
2+ in ipRGCs occurs after
photon capture by melanopsin and membrane depolarization
which is believed to be mediated via canonical transient receptor
potential (TRP) channels [20,28–30]. If in our study carbenox-
olone blocked TRP C channels then it would have inhibited the
light-induced rise in Ca
2+ by preventing the ipRGCs from
depolarizing and firing action potentials. However, carbenoxolone
did not alter light-evoked action potential generation in ipRGCs
[17,18] making it very unlikely that in our study carbenoxolone
inhibited TRP C channels in ipRGCs to any significant extent or
effected light-induced action potential generation.
Figure 4. Carbenoxolone inhibition of glutamate-evoked Ca
2+ responses in ipRGCs. (a) Carbenoxolone (CBX, 100 mM) completely blocked
the light-evoked rise in [Ca
2+]i and inhibited the glutamate-evoked elevation in [Ca
2+]i (b) Summary (means 6 SEM, normalized to the pretreatment
responses) illustrating the carbenoxolone inhibition of glutamate-evoked rise in Ca
2+ (following complete inhibition of the light-evoked Ca
2+
response). * p,0.01, Student’s t-test (n=7)
doi:10.1371/journal.pone.0022721.g004
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noxolone blocks L-type VGCC comes from the glutamate-evoked
elevation in [Ca
2+]i in ipRGCs described in this study. Glutamate
acting via glutamate receptors on ipRGCs produces membrane
depolarization followed by action potential generation and
activation of L-type VGCC; the glutamate evoked rise in Ca
2+
was significantly reduced by TTX which blocks action potential
generation. The residual Ca
2+ response in the presence of TTX
was from Ca
2+ entry via NMDA and/or AMPA/kainate-type
glutamate receptors which are permeable to Ca
2+. Thus, blocking
glutamate-evoked action potentials eliminates activation of L-type
VGCC. Indeed, we next demonstrated that verapamil, a selective
L-type VGCC antagonist, inhibited the glutamate-evoked rise in
Ca
2+ to the same degree as blockade by TTX. Thus if carbeno-
xolone blocked L-type VGCC, it would be predicted that car-
benoxolone would produce a similar level of antagonism as TTX
and verapamil; the carbenoxolone inhibition of the glutamate-
evoked elevation in [Ca
2+]i in ipRGCs was not significantly
different from that observed with TTX or verapamil. Taken
together, the data strongly suggest that carbenoxolone inhibits L-
type VGCC.
Although carbenoxolone is a widely used gap junction inhibitor,
the effects of carbenoxolone are difficult and at times impossible to
reverse, as reported here and as described in the literature.
Pharmacological agents that block gap junctions and are poten-
tially more easily reversible, such as the fenamates, have been
sought [31]. Flufenamic acid derivatives have been shown to block
gap junction coupling between neurons and meclofenamic acid is
a very effective gap junction blocker in the retina [26,32,33].
Importantly, meclofenamic acid has also been reported not to
reduce the number of retinal ganglion cells (ipRGCs) exhibiting
light-evoked action potentials, similar to carbenoxolone applica-
tion [18]. However, also similar to carbenoxolone, in the presence
of meclofenamic acid (100 mM), light-evoked increases in [Ca
2+]i
were completely blocked in individual immunopanned ipRGCs,
and the effect was not easily reversible (Bramley, Sollars and
Pickard, unpublished observations). Thus, inhibition of VGCC
should also be considered when using meclofenamic acid as a gap
junction blocker.
In summary, carbenoxolone, a water-soluble membrane per-
meant pharmacological agent derived from licorice root, inhibits
gap junctions but also has actions on other membrane channels
including VGCC. Thus it is not a compound that can be used
reliably when Ca
2+ responses are the outcome measure or
when attempting to assign a role for gap junctions in complex
physiological network responses such as those that occur in the
retina.
Materials and Methods
Ethics Statement
The use of animals in this study was approved by the University
of Nebraska-Lincoln Institutional Animal Care and Use Commit-
tee (ID 391) and all experiments were conducted according to
NIH guidelines in Principles of Laboratory Animal Care.
Immunopanned RGC Cultures
Isolation of melanopsin-expressing ipRGCs was performed as
previously described [20]. Briefly, Long-Evans rat pups (6-8 per
panning session) were killed at age 5–7 days postnatal by halo-
thane overexposure and decapitation. A single-cell retinal suspen-
sion was produced through enzymatic dissociation of dissected
retinas (in Ca
2+/Mg
2+-free Dulbecco’s phosphate-buffered saline
[DPBS] with papain and DNase) and mechanical trituration;
melanopsin-expressing RGCs were isolated using a melanopsin-
antibody panning protocol with a rabbit melanopsin antibody
(F7884) generated against the N-terminal 19 amino acid sequence
of rat melanopsin. Melanopsin-panned cells were plated into wells
containing a poly-D-lysine/laminin-coated Biocoat glass coverslip
and 750 ml of culture medium consisting of Neurobasal-A plus 2%
B27 supplements, 1 mM glutamine, 25 ng/ml BDNF, 10 ng/ml
CNTF, 5 mM forskolin, and 10 mg/ml gentamicin. Cultures were
maintained in the dark at 37uC in a humidified 5% CO2-air
atmosphere.
Calcium Imaging
After 1–2 days in culture, the coverslip-plated melanopsin-
panned cells were transferred to modified Hank’s balanced salt
solution (HBSS; 15 mM HEPES, 2.6 mM CaCl2, Mg
2+-free,
pH 7.4) containing 5 mM fura-2 AM calcium indicator dye for
30 min in the dark at 35uC. The fura-loaded cells were then
transferred to a microscope chamber that was constantly super-
fused with HBSS warmed to 33–35uC and bubbled with 100%
oxygen. All tested drugs were dissolved in the HBSS and delivered
to the chamber by a peristaltic pump at a rate of <1 ml/min.
For calcium imaging, a 100 W mercury lamp and the appro-
priate filters (excitation 340 or 380 nm; emission 510 nm) were
used to generate fura-2 fluorescence. A filter wheel alternated the
340 and 380 nm filters with a 400 ms excitation period for each
wavelength. Fluorescence images (12-bit) were captured with a
cooled charged-coupled device camera fitted to an Axioskop 2 FS
upright microscope using a water-immersion objective (N.A.
0.80W; Achroplan 40x). The images of RGC fluorescence at
340 and 380 nm excitation were calculated over a large area of the
RGC soma and converted to ratiometric (340/380 nm) images by
imaging software (Imaging Workbench 2.2; Axon Instruments,
Foster City, CA). The background fluorescence was measured
from a region on the coverslip devoid of RGCs and subtracted
from each image.
To minimize the intensity of the fura-2 excitation wavelengths
(and reduce potential ipRGC stimulation), 8 X 8 pixel binned
images were acquired. With this increased binning, adequate
fluorescence was attained after reducing the 340 and 380 nm
excitation intensities with 20.5 and 22.5 log neutral density
filters, respectively. Light responses were calculated as the D fura-2
ratio, the peak minus baseline fura-2 ratio. The baseline response
was calculated as the average fura-2 ratio of the 3 ratios acquired
prior to light or drug exposure and the peak was the maximum
fura-2 ratio observed in the 100 s following light offset or drug
termination.
The isolated cells were stimulated with broad-spectrum light
from a 100 W halogen bulb, with light passing through the
condenser underneath the microscope chamber. One minute light
stimuli were used and the halogen light was blocked every 10 s to
allow for the acquisition of fura-2 images. Light stimulation was
remotely triggered using an electronic shutter. The standard light
stimulus utilized in the experiments was measured as approxi-
mately 2.0610
13 photons/s/cm at 420 nm, 6.9610
13 photons/s/
cm at 480 nm, 1.7610
14 photons/s/cm at 540 nm and 3.3610
14
photons/s/cm at 600 nm.
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